Literature DB >> 33551870

Volumetric Deficit Within the Fronto-Limbic-Striatal Circuit in First-Episode Drug Naïve Patients With Major Depression Disorder.

Yiran Zhang1,2, Yun Yang1,2, Licheng Zhu1,2, Qing Zhu3, Yuxi Jia1,2, Lan Zhang1,2, Qinmu Peng4, Jiazheng Wang5, Jia Liu1,2, Wenliang Fan1,2, Jing Wang1,2.   

Abstract

Background: Depression is a major psychiatric disorder and the leading cause of disability worldwide. Previous evidence suggested certain pattern of structural alterations were induced by major depression disorder (MDD) with heterogeneity due to patients' clinical characteristics and proposed that early impairment of fronto-limbic-striatal circuit was involved. Yet the hypothesis couldn't be replicated fully. Accordingly, this study aimed to validate this hypothesis in a new set of first-episode, drug naïve MDD patients and further explore the neuroimaging biomarker of illness severity using whole-brain voxel-based morphometry (VBM). Materials and
Methods: A total of 93 participants, 30 patients with first-episode medication-naïve MDD, and 63 healthy controls were enrolled in the study. VBM was applied to analyze differences in the gray matter volume (GMV) between these two groups. The correlation between the GMV of the identified brain regions and the severity of clinical symptoms quantified by the Hamilton Depression Scale (HAMD) was further conducted in the post-hoc analysis to confirm the role of GMV structural alteration in clinical symptoms.
Results: Our results revealed that the brain gray matter volume of the prefrontal lobe, limbic system, striatum, cerebellum, temporal lobe, and bilateral lingual gyri were significantly decreased in MDD patients compared with healthy controls. Besides, the HAMD scores were negatively correlated with GMV of the right insula and positively correlated with that of the right lingual gyrus. Conclusions: Our findings provide robust evidence that gray matter structural abnormalities within the prefronto-limbic-striatal circuit are implicated in the pathophysiology of MDD at an early stage without confounding influence of medication status. Besides, our data suggest that the cerebellum, lingual gyrus, and fusiform gyrus should also be integrated into the brain alterations in MDD. Future synthesis of individual neuroimaging studies and more advanced statistical analysis comparing subfields of the aforementioned regions are warranted to further shed light on the neurobiology of the disease and assist in the diagnosis of this burdensome disorder.
Copyright © 2021 Zhang, Yang, Zhu, Zhu, Jia, Zhang, Peng, Wang, Liu, Fan and Wang.

Entities:  

Keywords:  drug naïve; first episode; limbic cortex; major depression; prefrontal cortex; striatum; voxel-based morphometry

Year:  2021        PMID: 33551870      PMCID: PMC7854541          DOI: 10.3389/fpsyt.2020.600583

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  60 in total

Review 1.  A revised limbic system model for memory, emotion and behaviour.

Authors:  Marco Catani; Flavio Dell'acqua; Michel Thiebaut de Schotten
Journal:  Neurosci Biobehav Rev       Date:  2013-07-09       Impact factor: 8.989

2.  Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis.

Authors:  Y-J Zhao; M-Y Du; X-Q Huang; S Lui; Z-Q Chen; J Liu; Y Luo; X-L Wang; G J Kemp; Q-Y Gong
Journal:  Psychol Med       Date:  2014-03-21       Impact factor: 7.723

3.  Brain volume alteration and the correlations with the clinical characteristics in drug-naïve first-episode MDD patients: a voxel-based morphometry study.

Authors:  Yu-Qi Cheng; Jian Xu; Pei Chai; Hai-Jun Li; Chun-Rong Luo; Tao Yang; Lin Li; Bao-Ci Shan; Xiu-Feng Xu; Lin Xu
Journal:  Neurosci Lett       Date:  2010-06-04       Impact factor: 3.046

4.  Functional dysconnectivity within the emotion-regulating system is associated with affective symptoms in major depressive disorder: A resting-state fMRI study.

Authors:  Zongling He; Fengmei Lu; Wei Sheng; Shaoqiang Han; Zhiliang Long; Yuyan Chen; Wei Luo; Yue Yu; Xiaoyu Nan; Aili Ouyang; Qian Cui; Huafu Chen
Journal:  Aust N Z J Psychiatry       Date:  2019-02-28       Impact factor: 5.744

Review 5.  Brain structure alterations in depression: Psychoradiological evidence.

Authors:  Fei-Fei Zhang; Wei Peng; John A Sweeney; Zhi-Yun Jia; Qi-Yong Gong
Journal:  CNS Neurosci Ther       Date:  2018-03-05       Impact factor: 5.243

6.  State-dependent changes in hippocampal grey matter in depression.

Authors:  D Arnone; S McKie; R Elliott; G Juhasz; E J Thomas; D Downey; S Williams; J F W Deakin; I M Anderson
Journal:  Mol Psychiatry       Date:  2012-11-06       Impact factor: 15.992

7.  Identification of a common neurobiological substrate for mental illness.

Authors:  Madeleine Goodkind; Simon B Eickhoff; Desmond J Oathes; Ying Jiang; Andrew Chang; Laura B Jones-Hagata; Brissa N Ortega; Yevgeniya V Zaiko; Erika L Roach; Mayuresh S Korgaonkar; Stuart M Grieve; Isaac Galatzer-Levy; Peter T Fox; Amit Etkin
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

8.  Resting-state functional connectivity bias of middle temporal gyrus and caudate with altered gray matter volume in major depression.

Authors:  Chaoqiong Ma; Jurong Ding; Jun Li; Wenbin Guo; Zhiliang Long; Feng Liu; Qing Gao; Ling Zeng; Jingping Zhao; Huafu Chen
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

9.  Recruiting for research studies using online public advertisements: examples from research in affective disorders.

Authors:  Toby Wise; Danilo Arnone; Lindsey Marwood; Roland Zahn; Karen E Lythe; Allan H Young
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-05       Impact factor: 2.570

10.  Insular and hippocampal gray matter volume reductions in patients with major depressive disorder.

Authors:  Mirjam Stratmann; Carsten Konrad; Harald Kugel; Axel Krug; Sonja Schöning; Patricia Ohrmann; Christina Uhlmann; Christian Postert; Thomas Suslow; Walter Heindel; Volker Arolt; Tilo Kircher; Udo Dannlowski
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

View more
  2 in total

Review 1.  Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Authors:  Maxemiliano V Vargas; Retsina Meyer; Arabo A Avanes; Mark Rus; David E Olson
Journal:  Front Psychiatry       Date:  2021-10-04       Impact factor: 4.157

2.  Reduced Brain Gray Matter Volume in Patients With First-Episode Major Depressive Disorder: A Quantitative Meta-Analysis.

Authors:  Ruiping Zheng; Yong Zhang; Zhengui Yang; Shaoqiang Han; Jingliang Cheng
Journal:  Front Psychiatry       Date:  2021-07-01       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.